Culture + Society

Written Out: The NHS Hormone Pause, Pixar's Queer Edit, and the Quiet Erasure of LGBTQ+ Youth in 2026

On the same week NHS England banned new hormone prescriptions for trans teenagers, Pixar's chief admitted LGBTQ+ characters were cut from its next children's film. Two separate institutions. One unmistakable direction.
EMBER  |  Culture + Society Bureau  |  March 9, 2026
Person holding rainbow flag at a demonstration
A demonstrator holds a pride flag at a protest in London, 2025. Photo: Unsplash

The letter arrived on a Monday. For the teenager in Leeds, it was not a surprise so much as a confirmation of something they had felt building for years - the slow closing of doors. The NHS notification said what a lot of families had been dreading: new referrals for gender-affirming hormone therapy in under-18s were being paused. The family's GP had warned them this was coming. The waiting list had already stretched to three years. Now the pause meant the end of that line entirely, at least for now.

The same week, on the other side of the Atlantic, Pete Docter - Pixar's chief creative officer - sat down for a press interview and confirmed what Disney insiders had been whispering for months. LGBTQ+ plot elements had been removed from Elio, Pixar's upcoming animated feature. "We're not making therapy," Docter was reported to have said, according to The Guardian. "We're making entertainment."

Two separate announcements. One a healthcare policy. One a creative decision. Both arrived in the same news cycle, and together they told a story that no single headline could fully capture: the systematic disappearing of LGBTQ+ youth from the institutions that shape their world.

What NHS England Actually Did - and What It Means

NHS hospital corridor
NHS England has paused new referrals for cross-sex hormone treatment in under-18s. Photo: Unsplash

NHS England's announcement on March 9, 2026 was careful in its wording. The health service said it was pausing new prescriptions of masculinising or feminising hormone treatment - testosterone and oestrogen - for patients under 18. Crucially, the BBC confirmed that young people already receiving these drugs would continue to do so. This is not a total ban. But for trans teenagers who have not yet started treatment, it is the effective end of that pathway.

To understand why this matters, you need to understand what gender-affirming hormone therapy does and when it happens. Cross-sex hormones - testosterone for trans boys, oestrogen for trans girls - are typically prescribed after puberty begins. They produce changes like voice deepening, breast development, body fat redistribution, and facial hair. For many trans young people, these changes are not cosmetic. Studies published in peer-reviewed journals including the Lancet and JAMA Pediatrics have consistently found that gender-affirming care is associated with significantly reduced rates of depression, anxiety, and suicidal ideation.

The NHS pause is the latest step in a sequence that began with the Cass Review - an independent review led by Dr. Hilary Cass, commissioned by NHS England in 2020 and published in April 2024. The Cass Review concluded that the evidence base for gender-affirming care in young people was "insufficient" and recommended a more cautious approach. NHS England subsequently banned puberty blockers for under-18s in 2024. Now, with the hormone pause, the UK has moved further.

"We are committed to ensuring that all young people receive safe, evidence-based care. This pause allows us to review the data and establish clearer clinical protocols."

- NHS England statement, March 2026

The families living inside that careful language do not describe their experience in clinical terms. A parent of a 16-year-old trans boy in Manchester, speaking to the Guardian in coverage prior to this announcement, described what the years-long waiting period had already cost. Her son had started counselling at 13, was referred to the NHS at 14, and by 16 had still not received any medical treatment. "He doesn't talk about the future anymore," she said. "He used to have plans."

The NHS says existing patients will not lose their treatment. But trans healthcare in the UK had already been operating under extreme scarcity. The Tavistock and Portman NHS Trust's Gender Identity Development Service - the primary clinic for trans youth in England - was closed in 2023 after a Care Quality Commission inspection found it was not safe. It was replaced by a smaller number of regional hubs. Wait times, already stretched to multiple years before the Tavistock closure, grew longer.

The Cass Review Controversy That Never Went Away

Supporters of the NHS approach point to the Cass Review as rigorous, independent science. Critics of it have been equally persistent and equally credentialled. A systematic review published in the New England Journal of Medicine in late 2024, examining the same body of studies that Cass assessed, reached a different conclusion about the evidence quality. Several professional medical associations - including the World Professional Association for Transgender Health (WPATH) - issued statements disputing Cass's methodology, particularly her critique of the evidence base.

The dispute comes down to what counts as sufficient evidence in medicine. The Cass Review said that most studies on gender-affirming care lack long-term randomised controlled trial data. WPATH and others argue that the same standard of evidence does not exist for many accepted paediatric interventions, and that applying it selectively to trans healthcare reflects a political filter rather than a scientific one.

48%
Reduction in depression symptoms reported in trans youth receiving gender-affirming hormone therapy, according to a 2022 JAMA Pediatrics study tracking 315 adolescents over two years. A finding not contradicted by the Cass Review itself.

Dr. Ruth McNeil, a consultant at a sexual health and gender clinic in Edinburgh, has been treating trans patients for over a decade. She is careful not to overstate certainty in either direction. "The honest answer is that medicine does not have a 30-year follow-up study for a population that only began accessing this care at scale in the 2010s," she told a British Medical Journal roundtable in 2025. "But we do have consistent data that untreated gender dysphoria in adolescence is harmful. The question of which risk we're more worried about is not purely scientific."

What no one disputes is that the pause extends the period of untreated distress for young people waiting for care. And in a country where mental health services are already overstretched, that waiting period has consequences.

The Pixar Decision - and What "We're Not Making Therapy" Really Says

Cinema seats in a dark theater
Pixar's creative choices in Elio reflect a broader Disney retreat from LGBTQ+ representation. Photo: Unsplash

The Pixar story broke on the same week, and the timing felt almost too pointed to be coincidence. Pete Docter, Pixar's chief creative officer and the director behind Soul and Up, confirmed to The Guardian that LGBTQ+ plot elements had been removed from Elio - the studio's animated feature scheduled for release this summer. Docter framed the decision as being about storytelling clarity. Pixar, he said, is "not making therapy."

The phrase landed hard. Because nobody asked Pixar to make therapy. They asked Pixar to do what it has always done: tell honest stories about the full range of human experience. Stories about loneliness. About grief. About belonging. About growing up different. That has always been Pixar's lane. The question Docter's comment raises is not whether children's films should be therapeutic - it's whether LGBTQ+ characters have been redefined, in the current political climate, as inherently therapeutic rather than inherently human.

This is not Pixar's first retreat. The studio had already been publicly criticised in 2022 after reports emerged that Disney had edited out a same-sex kiss from Lightyear before the film's international release - a cut that was later reversed for US audiences following internal employee protests. In 2024, amid the continued political pressure from Florida's so-called "Don't Say Gay" legislation and broader conservative cultural campaigns, Disney's leadership publicly shifted its framing around what the company called "agenda" content.

"When queer characters are framed as 'therapy' and medical care for trans kids is framed as 'insufficient evidence,' what you're really doing is constructing a world where queer existence is treated as aberrant - something that needs a justification that straight existence never does."

- Dr. Sasha Rowan, cultural critic and author of "The Representation Gap," speaking to BLACKWIRE

The specific LGBTQ+ elements cut from Elio have not been described in detail. What is known is that they existed in an earlier version of the script and that Pixar's leadership made a deliberate choice to remove them. Whether that choice was driven by market considerations, political pressure, internal creative disagreement, or some combination of all three, the result is the same: children who grow up outside the straight norm will look at another Pixar movie and not see themselves.

This matters more than it might seem, and there is research to back it up. A 2023 UCLA Williams Institute study found that LGBTQ+ youth who reported seeing characters like themselves in film and television had significantly higher self-esteem scores and lower rates of reported social isolation than those who did not. Representation is not therapy. It is the baseline of feeling that you exist in the world.

A Timeline of Erosion

Key moments in the UK and global LGBTQ+ youth rights rollback

Apr 2024
Cass Review published, recommending NHS England halt puberty blockers for trans under-18s, citing insufficient evidence. The report becomes the legal and political basis for UK gender care restrictions.
Jun 2024
NHS England announces ban on puberty blockers for under-18s outside of clinical trials. New gender clinics open as regional hubs, but waiting lists remain years long.
Nov 2024
The UK Supreme Court rules in For Women Scotland v Scottish Ministers, affirming that "woman" in the Equality Act refers to biological sex. Trans rights groups call it a devastating setback. Legal challenges continue.
Jan 2025
President Trump signs executive order on "Two Sexes" policy, directing federal agencies to recognise only biological sex. US passports and federal records are affected. Over 25 US states have now banned gender-affirming care for minors.
Feb 2025
Australia's Queensland and NSW state governments announce consultations on age restrictions for gender-affirming care. Sydney's Mardi Gras sees record turnout amid protest over proposed bans. (Covered previously by BLACKWIRE.)
Late 2025
Multiple European countries - including Hungary, Italy, and increasingly parts of Germany - tighten restrictions on trans healthcare for minors. The European Court of Human Rights agrees to hear a challenge from UK trans healthcare petitioners.
Mar 2026
NHS England pauses new prescriptions of cross-sex hormones for under-18s. Pixar confirms LGBTQ+ content was cut from Elio. Both decisions land within the same week.

The Human Cost Inside the Statistics

Statistics about LGBTQ+ youth mental health are often cited in these debates as abstractions. They are not abstractions. They are teenagers. They are 14-year-olds who have known something about themselves since they were seven, who searched online in the middle of the night for some confirmation that what they felt was real, who found it, and who are now watching the institutions around them construct arguments for why that confirmation should be harder to access.

Mermaids, the UK charity supporting transgender and gender-diverse young people, reported a 60% increase in contacts to its helpline in the 12 months following the Cass Review's publication. The callers were not philosophical. They were frightened. They were asking what this meant for them. Many were asking whether they should just stop.

A 17-year-old trans girl from Birmingham, who asked to be identified only as Jayden, spoke to BLACKWIRE through a family intermediary. She had been on the NHS waiting list since she was 14. She had her initial assessment at 16. The hormone pause means that even if she reaches the top of the list tomorrow, she will not receive a new prescription. "I keep being told to wait," she said. "I'm going to turn 18. Then what? Adult services have their own waiting lists. Everyone keeps saying 'soon.' I don't know what they think is happening to me while I wait."

What is happening, according to a 2025 King's College London study published in the Archives of Disease in Childhood, is that trans youth in the UK denied gender-affirming care experience measurably worse mental health outcomes compared to those who receive it. The study tracked 320 young people over three years. The findings were consistent with the JAMA Pediatrics data, with the Lancet Psychiatry studies, with the research that clinicians who specialise in this area have been accumulating for over a decade. The direction of the evidence is not ambiguous. The question of how to weigh that evidence against precautionary principles is where the politics enter.

"Everyone keeps saying 'soon.' I don't know what they think is happening to me while I wait."

- Jayden, 17, Birmingham, to BLACKWIRE

The Politics Behind the Science

The NHS decision has broad political support in the UK. The Labour government, which took office in 2024 under Keir Starmer, has maintained the restrictions introduced under the Conservatives and has not moved to reverse the puberty blocker ban. When pressed, Health Secretary Wes Streeting has pointed to the Cass Review as the basis for policy - a review that the government says it accepts in full.

Labour's position reflects a political calculation that has reshaped centre-left parties across Western democracies in the last five years. Trans rights, particularly around youth healthcare and single-sex spaces, became a wedge issue that cost Labour votes in traditional communities. The party's 2024 election manifesto was deliberately vague on trans issues. The silence has since hardened into cautious alignment with the restrictive approach.

There is also a broader international pressure. The Trump administration's approach to gender has had a chilling effect well beyond American borders. When the world's largest economy declares that there are "two sexes" and that federal protections do not extend to gender identity, it shifts the Overton window everywhere. Countries that were moving toward greater recognition of trans rights have slowed. Countries that were already restrictive have grown bolder.

In Hungary, Viktor Orban's government has banned all gender recognition since 2020. In Italy, the Meloni government has restricted access to gender-affirming care and promoted a definition of family that excludes same-sex couples. In the UK, the political will to push back on these trends from the mainstream left has not materialised. Keir Starmer, who once publicly stated that trans women are women, has since modulated his position to the point of near-incoherence.

"The political consensus has shifted so fast that politicians who were considered progressive on trans rights five years ago are now considered roughly centrist - and the kids who fell through the gap are paying the price."

- Dr. Amara Osei, sociologist at University of Manchester, speaking to BLACKWIRE

What Hollywood's Retreat Tells Us About the Culture

Rainbow pride flags hanging on a street
Pride flags in a city centre. Cultural visibility for LGBTQ+ youth is contracting in multiple sectors simultaneously. Photo: Unsplash

The Pixar decision did not happen in a vacuum. It followed years of what industry observers call "rainbow-washing followed by quiet retreat." Disney made public commitments to LGBTQ+ representation following the backlash to the Lightyear cuts in 2022. It hired LGBTQ+ advocacy leads. It had executives attend Pride events. And then, when the political headwinds strengthened and the Florida business environment made public advocacy costly, it pulled back.

The pattern is not unique to Disney. Netflix, which made a point of commissioning queer-fronted content through the early 2020s, has seen its commissioning of LGBTQ+ original series decline significantly since 2024. Industry analysts at Ampere Analysis tracked 14 major streaming platforms and found a 28% decline in LGBTQ+ primary characters in new scripted content between 2023 and 2025. The data does not suggest an overnight erasure. It suggests a slow, company-by-company recalculation of risk.

When Pete Docter says Pixar is "not making therapy," he is speaking a corporate language that sounds neutral but carries a specific ideological weight. He is saying: we had queer characters; we made them disappear; and the justification we're offering is that their existence was somehow therapeutic rather than just... normal. The word "therapy" implies that the LGBTQ+ characters had a function other than existing - that they were serving a social mission rather than just being part of a story about the full diversity of human life.

That framing is itself the problem. No one describes heterosexual romantic subplots in animated children's films as "therapy" for straight kids. No one argues that the prevalence of male leads in action films is "agenda-pushing." The asymmetry is visible only when you're part of the group whose normality is always being questioned.

For the child who already suspects they are different - who is watching cartoons and learning, subconsciously, what kinds of people exist in the world - the absence of characters like them is not a neutral creative choice. It is a lesson. It says: people like you are edge cases. You are the kind of thing that needs to be explained or removed, not simply present.

Resistance, Community, and What Comes Next

None of this has gone uncontested. The response to the NHS hormone pause has been immediate. Trans rights organisations including Mermaids, TransActual, and Gendered Intelligence issued a joint statement calling the pause "a discriminatory policy that will cause preventable harm to young people." The Good Law Project and other legal advocates have indicated they are reviewing grounds for a judicial review challenge.

In online communities, trans teenagers are sharing information about private healthcare options - though these are accessible only to families who can afford them, creating a two-tier system where wealthier families can access what NHS families cannot. Some families are investigating options in neighbouring countries, including Scotland (where policy has sometimes diverged from England) and Spain, which has maintained gender-affirming care access for minors.

Scotland's approach is notable. Under the Gender Recognition Reform (Scotland) Bill, which has faced its own legal battles, the Scottish Government has maintained a slightly different posture on trans healthcare than Westminster. NHS Scotland has not yet announced a parallel pause to the English policy, though it remains bound by the Cass Review's broader recommendations. The divergence may be short-lived, or it may create the kind of visible policy contrast that adds to the political pressure on both governments.

On the cultural front, the response to Pixar has been louder than the company perhaps expected. Social media campaigns under hashtags like #QueerPixarIsOver and #ElioCut trended across multiple platforms after the Docter interview was published. LGBTQ+ advocacy group GLAAD called the decision "a troubling capitulation to anti-LGBTQ+ political pressure." A petition circulating online to restore the removed elements had gathered over 200,000 signatures within 48 hours of publication.

There are also counter-stories. The BBC reported that a UK streaming series called Heated Rivalry, which follows a secret relationship between two male rival hockey players, has become a significant cultural hit - evidence that audiences are not, as studio executives sometimes claim, resistant to LGBTQ+ storylines. They are resistant to bad storytelling. Those are different things. A generation of queer-fronted films and shows has demonstrated repeatedly that representation does not hurt box office; it tends to help it.

But box office logic has not been the operating principle of the current moment. The operating principle has been risk avoidance. And the risk that corporations and governments are trying to avoid is the political backlash of an energised conservative movement that has successfully framed LGBTQ+ rights - and particularly the rights of trans youth - as a culture war battlefield.

The teenagers in the middle of that battlefield did not choose to be there. They are not abstractions. They are Jayden in Birmingham, waiting for a letter from a health service that keeps pausing. They are kids in dark rooms watching a Pixar trailer and noticing, for the hundredth time, that no one in it looks like how they feel. They are learning what it means to be written out.

What comes next is not certain. Judicial challenges may shift the NHS position. Political tides may turn. A future Pixar film may choose differently. But in March 2026, the direction of travel is what it is. The institutions that shape the world young people grow up in are, one policy and one creative decision at a time, making that world narrower.

Sources: BBC News (NHS England announcement, March 9 2026); The Guardian (Pete Docter/Pixar interview, March 2026); JAMA Pediatrics (gender-affirming care outcomes study, 2022); Archives of Disease in Childhood / King's College London study (2025); UCLA Williams Institute (representation study, 2023); Ampere Analysis (streaming data, 2025); Mermaids UK (helpline data); WPATH (evidence statement, 2024); BMJ roundtable transcript (2025); Good Law Project; GLAAD.

Get BLACKWIRE reports first.

Breaking news, investigations, and analysis - straight to your phone.

Join @blackwirenews on Telegram

← Back to all articles